Certain companies may be covered by FRC under an issuer paid model. FRC or companies with related management, and Analysts, may hold shares/securities in some companies mentioned in this section. This creates a potential conflict of interest which readers should consider.
In this video, our equity analyst will share some recent development in the psychedelic market in Canada and a new company in this market which we will be initiating coverage on very soon. The psychedelic market has seen a surge in popularity in recent years. However, research on how psychedelics can be used to treat mental health conditions is still in its early stages, and much more will be needed to determine whether psychedelics, including psilocybin, are an effective long-term treatment.
The psychedelic industry is experiencing a newfound renaissance as investors are beginning to acknowledge the advantages of psychedelic drugs in treating mental health conditions.